Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

v3.23.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Summary of Stock Option Activities

The following table summarizes stock option activities for the nine months ended September 30, 2023:

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted Average

​

​

​

​

​

​

​

Remaining

​

​

​

​

Weighted Average

​

Contractual Life (in

​

​

Stock Options

​

Exercise Price

​

years)

Outstanding at December 31, 2022

 

76,112

​

$

59.09

 

4.31

Outstanding at September 30, 2023

 

76,112

​

$

59.09

 

3.56

Options vested and exercisable at September 30, 2023

 

47,570

​

$

59.09

 

3.56

Schedule of Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022 (in thousands):

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

For the three months ended September 30, 

​

For the nine months ended September 30, 

​

    

2023

    

2022

    

2023

    

2022

General and administrative

​

$

119

​

$

194

​

$

381

​

$

549

Research and development (1)

​

 

(19)

​

 

302

​

 

(1)

​

 

1,261

Total stock-based compensation expense

​

$

100

​

$

496

​

$

380

​

$

1,810

​

(1) The credit in research and development stock-based compensation expense reflects the reversal of expense related to Restricted Stock Unit forfeitures during the three and nine months ended September 30, 2023.

Summary of Warrant Activities

A summary of warrant activities for the nine months ended September 30, 2023, is presented below:

​

​

​

​

​

​

​

​

​

​

    

​

    

​

​

    

Weighted Average

​

​

​

​

​

​

​

Remaining

​

​

​

​

Weighted Average

​

Contractual Life (in

​

​

Warrants

​

Exercise Price

​

years)

Outstanding as of December 31, 2022

 

70,195

​

$

22.80

 

8.29

Exercised

 

(93)

​

 

—

 

—

Outstanding as of September 30, 2023

 

70,102

​

$

22.80

 

7.55

Restricted Stock Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedules of Restricted Stock and Restricted Stock Unit Activity

The following table summarizes restricted stock award activities for the nine months ended September 30, 2023:

​

​

​

​

​

​

​

​

    

​

    

Weighted Average

​

​

​

​

Grant Date Fair

​

​

Number of Shares

​

Value

Nonvested at December 31, 2022

 

34,016

​

$

22.20

Granted

 

36,230

​

 

6.90

Vested

​

(5,540)

​

​

46.20

Nonvested at September 30, 2023

 

64,706

​

$

11.59

Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedules of Restricted Stock and Restricted Stock Unit Activity

Certain employees and consultants have been awarded restricted stock units with time-based vesting. The following table summarizes restricted stock units’ activities for the nine months ended September 30, 2023:

​

​

​

​

​

​

​

​

    

​

    

Weighted Average

​

​

​

​

Grant Date Fair

​

​

Number of Units

​

Value

Nonvested at December 31, 2022

 

165,912

​

$

27.60

Granted

 

29,732

​

 

5.13

Forfeited

​

(46,172)

​

​

27.93

Vested

 

(43,372)

​

 

32.82

Nonvested at September 30, 2023

 

106,100

​

$

19.03